CTI BioPharma Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	1,073	757	320	463	1,249	559	Upgrade
Market Cap Growth	13.48%	136.81%	-30.93%	-62.93%	123.29%	309.64%	Upgrade
Enterprise Value	1,189	841	506	678	1,339	734	Upgrade
Last Close Price	1.28	1.08	0.65	9.48	32.17	25.20	Upgrade
PS Ratio	2487.17	1092.66	228.50	-	-	132.62	Upgrade
PB Ratio	-42.44	-19.20	-2.56	-2.89	-10.51	-1.39	Upgrade
EV/Sales Ratio	-	1213.75	361.95	-	-	173.99	Upgrade
Debt / Equity Ratio	-5.20	-3.85	-1.44	-1.37	-1.62	-0.56	Upgrade
Asset Turnover	0.00	0.01	0.02	-	-	0.05	Upgrade
Quick Ratio	0.36	0.63	0.50	0.49	0.86	0.16	Upgrade
Current Ratio	0.61	0.94	0.76	0.68	1.09	0.21	Upgrade
Return on Assets (ROA)	-55.72%	-73.40%	-109.04%	-134.44%	-135.19%	-74.82%	Upgrade
Return on Capital (ROIC)	-68.55%	-88.82%	-149.16%	-176.09%	-	-	Upgrade
Earnings Yield	-10.86%	-19.39%	-53.61%	-49.73%	-21.87%	-59.46%	Upgrade
FCF Yield	-7.29%	-14.65%	-41.14%	-36.12%	-11.56%	-18.73%	Upgrade
Buyback Yield / Dilution	-92.71%	-166.25%	-425.90%	-10.89%	-344.19%	-571.03%	Upgrade

Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.